T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers Meeting Abstract

   

Authors:	Ma, J.; Klatt, M.; Dundar, F.; Zumbo, P.; Femia, M.; Betel, D.; Scheinberg, D.; Baker, B.; Klebanoff, C.; Chandran, S.
Abstract Title:	T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers
Meeting Title:	34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019)
Journal Title:	Journal for ImmunoTherapy of Cancer
Volume:	7
Issue:	Suppl. 1
Meeting Dates:	2019 Nov 6-10
Meeting Location:	National Harbor, MD
ISSN:	2051-1426
Publisher:	Biomed Central Ltd
Date Published:	2019-11-01
Start Page:	282
Language:	English
ACCESSION:	WOS:000496473200595
PROVIDER:	wos
PMCID:	PMC6833189
PUBMED:	31694725
DOI:	10.1186/s40425-019-0763-1
Notes:	Meeting Abstract: P171 -- Source: Wos